Impact of Anticoagulant and Antiplatelet Therapy on the National Optimal Lung Cancer Pathway (NOLCP)
RoB medications were associated with meaningful delays from clinic to biopsy, challenging NOLCP's three-day biopsy target. Early identification and proactive management of these patients at triage, along with flexible procedural scheduling, are essential to reduce delays and improve diagnostic timelines.
Authors
- Helen McDill
- Cyrus Daneshvar (ORCID: https://orcid.org/0000-0003-0956-8674)
- A Jagła
- Maged Hassan (ORCID: https://orcid.org/0000-0002-8768-6548)
Institutions
- Southmead Hospital (GB)
- Derriford Hospital (GB)
- University Hospitals Plymouth NHS Trust (GB)
- Alexandria University (EG)
Publication Details
- Journal
- Cureus
- Published
- 2025-09-12
- DOI
- https://doi.org/10.7759/cureus.92169
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00